These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10267722)

  • 1. Competition: past, present, future.
    Kaiser LR
    Group Pract J; 1984; 33(1):14-5, 18-20. PubMed ID: 10267722
    [No Abstract]   [Full Text] [Related]  

  • 2. Adding value is a must for survivors and thrivers.
    Shortell SM
    Healthc Exec; 1990; 5(3):17-9. PubMed ID: 10105272
    [No Abstract]   [Full Text] [Related]  

  • 3. Competition--Part I: what part will you play in the medical care "firms" of the future?
    Ellwood PM; Malcolm JK; Lewis KA
    Group Pract J; 1982; 31(4):8-10. PubMed ID: 10257374
    [No Abstract]   [Full Text] [Related]  

  • 4. Are you managing a future national medical practice?
    Hammerle RL
    Med Group Manage; 1983; 30(4):36-8. PubMed ID: 10262409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition breeds tensions among Albuquerque MDs.
    Golin CB
    Am Med News; 1983 May; 26(19):1, 3, 11-2. PubMed ID: 10264144
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of healthcare: competition.
    Iwan M
    Healthc Comput Commun; 1985 Dec; 2(12):30-2. PubMed ID: 10274791
    [No Abstract]   [Full Text] [Related]  

  • 7. Competition within the firm: theory plus some evidence from medical group practice.
    Gaynor M
    Rand J Econ; 1989; 20(1):59-76. PubMed ID: 10296626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to hospitals: a look at the growing competition.
    Unger WJ
    MLO Med Lab Obs; 1983 Jan; 15(1):32-5. PubMed ID: 10313987
    [No Abstract]   [Full Text] [Related]  

  • 9. A forecast for the future.
    Blackwell RD; Johnston WJ
    Internist; 1983 Apr; 24(3):10-2. PubMed ID: 10260155
    [No Abstract]   [Full Text] [Related]  

  • 10. Competition and deregulation: an architect for change discusses their impact on group practice.
    Enthoven AC
    Group Pract J; 1981; 30(8):7-10, 16-9, 24. PubMed ID: 10253015
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives. FTC facing an uncertain future.
    Wash Rep Med Health; 1983 Jul; 37(27):4p. PubMed ID: 10262595
    [No Abstract]   [Full Text] [Related]  

  • 12. Coping with competition.
    Reinsel SJ
    Internist; 1982 Nov; 23(9):14-6. PubMed ID: 10258712
    [No Abstract]   [Full Text] [Related]  

  • 13. The new health policy: promises and pitfalls.
    Marmor TR
    Health Policy Q; 1982; 2(2):70-8. PubMed ID: 10259097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic competition: has the "solution" become the problem?
    Curtin LL
    Nurs Manage; 1989 May; 20(5):7-8. PubMed ID: 2726081
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of competition in medicine.
    J Tenn Med Assoc; 1983 Sep; 76(9):588-92. PubMed ID: 6632878
    [No Abstract]   [Full Text] [Related]  

  • 16. How megaclinics are building competitive clout.
    Holoweiko M
    Med Econ; 1992 Apr; 69(8):98-101, 104, 107 passim. PubMed ID: 10117543
    [No Abstract]   [Full Text] [Related]  

  • 17. Guest relations: a source of competitive advantage.
    Hosp Guest Relations Rep; 1988 May; 3(5):10-1. PubMed ID: 10286850
    [No Abstract]   [Full Text] [Related]  

  • 18. The need for fundamental reform through competition and rational economic incentives.
    Enthoven AC
    Issues Health Care; 1981; 2(1):2-7. PubMed ID: 10253121
    [No Abstract]   [Full Text] [Related]  

  • 19. Gut issues in competitive strategy development.
    Berkowitz EN
    Group Pract J; 1984; 33(4):30-6. PubMed ID: 10270102
    [No Abstract]   [Full Text] [Related]  

  • 20. Competition for the health dollar: the pathologist's share.
    Olsen HV
    Pathologist; 1983 Feb; 37(2):122-4. PubMed ID: 10261175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.